Clinical Trials Browser

Recruiting × Lymphoma × Bendamustine Hydrochloride × Clear all

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Neoplasms

NCT06522737 2026-04-06

TERZO

Phase 3 Recruiting

124 enrolled

Lymphoid

Immunoblastic Lymphadenopathy, Lymphoma, Recurrence, Lymphoma, T-Cell, Peripheral

NCT06084936 2026-04-02

GLOBRYTE

Phase 3 Recruiting

182 enrolled

Lymphoid

Lymphoma

NCT06854003 2026-02-20

BRAZAN

Phase 2 Recruiting

60 enrolled

Lymphoid

Lymphoma, Lymphoma, Mantle-Cell

NCT04223765 2026-01-20

Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

Phase 1 Recruiting

20 enrolled

Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT04083495 2025-09-22

CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma

Phase 2 Recruiting

20 enrolled

Lymphoid

Lymphoma, Lymphoma, T-Cell, Peripheral

NCT04792489 2025-04-24

DALY II USA/ MB-CART2019.1 for DLBCL

Phase 2 Recruiting

248 enrolled

CNSLymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Central Nervous System Neoplasms, Lymphoma, Mantle-Cell

NCT05848765 2023-11-29

REFRACT

Phase 2 Recruiting

284 enrolled

Lymphoid

Lymphoma, Lymphoma, Follicular

NCT05899621 2023-06-12

A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL

Recruiting

332 enrolled

Lymphoid

Lymphoma, Lymphoma, Follicular

Clinical Trials

EPCORE™FL-2

TERZO

GLOBRYTE

BRAZAN

Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma

DALY II USA/ MB-CART2019.1 for DLBCL

REFRACT

A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL